|

Effects of Resistance and Aerobic Exercises on Walking and Sarcopenic Parameters in Parkinson's Disease

RECRUITINGN/ASponsored by Ahi Evran University Education and Research Hospital
Actively Recruiting
PhaseN/A
SponsorAhi Evran University Education and Research Hospital
Started2025-09-10
Est. completion2026-01-01
Eligibility
Age40 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07165106

Summary

The aim of this study was to investigate the effects of resistance and aerobic exercises on the following outcomes in patients with sarcopenic Parkinson's disease: Timed Up and Go Test (TUG), gait speed, Short Physical Performance Battery (SPPB), handgrip strength, Five-Times Sit-to-Stand Test, and MDS-UPDRS Part II scores.

Eligibility

Age: 40 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* Male and female patients aged 40-85 years with a clinical diagnosis of Parkinson's disease.
* Diagnosis of sarcopenia according to the EWGSOP2 criteria.
* Hoehn \& Yahr stage 2-3.
* Ability and willingness to provide written informed consent according to the approved study consent form.

Exclusion Criteria:

* Failure to meet diagnostic criteria for sarcopenia.
* Hoehn \& Yahr stage 1 or 4.
* History of malignancy.
* Epilepsy.
* History of cardiac pacemaker implantation.
* Presence of congestive heart failure.
* Orthopedic conditions affecting walking or balance.
* Respiratory disorders impairing exercise capacity.
* Uncontrolled hypertension.
* Inability to cooperate with study procedures.
* History of neuromuscular or vestibular disorders affecting gait or balance parameters.
* Lack of willingness to participate in the study.

Conditions3

PARKINSON DISEASE (Disorder)Parkinson's DiseaseSarcopenia

Browse More Trials

Parkinson's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.